EC17 for Intraoperative Imaging in Occult Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 12, 2014

Study Completion Date

November 12, 2014

Conditions
Ovarian Cancer
Interventions
DRUG

EC17

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT02000778 - EC17 for Intraoperative Imaging in Occult Ovarian Cancer | Biotech Hunter | Biotech Hunter